The QualityStocks Daily Monday, May 11th, 2020

Today's Top 3 Investment Newsletters

QualityStocks (TKLS) +82.86%

StreetInsider (MARK) +72.12%

MarketClub Analysis (APOP) +66.67%

The QualityStocks Daily Stock List

EGF Theramed Health Corp. (EVAHF)

Stocks News Feed, Stockwatch, Penny Stock Hub, HotOTCStocks, Insider Financial, BioPortfolio, OTC Markets, Lamp News, Investing.com, Central Charts, Seeking Alpha, InvestorX, Baystreet.ca, Barchart, Finance Recorder, Micro Small Cap, InvestorsHub, Investcom, and Big News Network reported beforehand on EGF Theramed Health Corp. (EVAHF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

EGF Theramed Health Corp. is a technology company listed on the OTC Markets Group’s OTCQB. It is focused in the healthcare and life sciences sector to develop a personalized healthcare system. EGF Theramed Health has now been centering on using CBD (cannabidiol) derived from hemp as a core component. The Company previously went by the name Theramed Health Corporation. It changed its name to EGF Theramed Health Corp. in October of 2019. EGF Theramed Health has its corporate office in Vancouver, British Columbia.

EGF Theramed, by way of its subsidiaries, has assets and technologies involved in extracting and purifying CBD extracts, creating formulations through its key scientists, and with its medical device technology monitoring capabilities. The Company provides automated online services for solving common health problems. Its goal is to be the first to offer a complete quality assured integrated "Natural Products Health Monitoring System" to improve one’s health conditions.

The Company’s online system is targeted chiefly at "practicing patients" interested in normalizing blood pressure, blood glucose, as well as body weight. EGF Theramed’s device enables physiologically interactive health apps useful in testing, tracking, and treating common health conditions. Fundamentally, its vision is to help improve health via personalized medical care (including Natural Products usage monitoring and its effects on the cardiovascular system), molecular biology, nutraceutical solutions, and genetics.

EGF Theramed Health continues to develop products, technologies, and also diagnostic tools focused on hemp-derived cannabidiol. Moreover, the Company has started its due diligence and research procedures in search of new investment opportunities in the psilocybin sector to diversify and strengthen its existing asset base. In addition, it has started to research psilocybin and psychedelics extraction and processing for its Las Vegas extraction lab. Psilocybin has been decriminalized in Denver, Oakland, and Santa Cruz and the Food and Drug Administration (FDA) in the United States granted a breakthrough therapy designation for the compound.

Last week, EGF Theramed Health announced that it closed on the joint venture (JV) transaction with Pharmadelic Labs Corp., earlier announced on May 4, 2020. With the announced JV and Share Purchase Agreement with Pharmadelic Labs and its shareholders, EGF Theramed Health acquired a 30 percent equity interest in Pharmadelic Labs via the issuance of an aggregate of 4,000,000 of its common shares to the shareholders of Pharmadelic Labs. Additionally, the Company issued 225,000 common shares as transaction fees to arm's length parties.

Pharmadelic Labs is a private Nevada corporation. It has research facilities in the Provinces of British Columbia and Alberta. With the terms of the Agreement, the parties will collaborate at EGF Theramed Health's lab facilities in Nevada for the further development and commercial exploitation of certain of Pharmadelic Lab's intellectual property (IP) centered on creating biosynthesis pathways for psilocybin.

EGF Theramed Health Corp. (EVAHF), closed Monday's trading session at $0.9968, up 2.2726%, on 142 volume with 4 trades. The average volume for the last 3 months is 397 and the stock's 52-week low/high is $0.080099999/$0.409999996.

chart

Fortress Biotech, Inc. (FBIO)

Zacks, Stocktwits, Streetwise Reports, Morningstar, Equities.com, Seeking Alpha, Stockhouse, GlobeNewswire, YCharts, Stockwatch, Stock News, BioPharmCatalyst, Infront Analytics, Macrotrends, Investing.com, ETF.com, Preferred Stock Channel, Market Chameleon, Nasdaq, Stockopedia, Market Screener, GuruFocus, TMXmoney, and Simply Wall St reported beforehand on Fortress Biotech, Inc. (FBIO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring, developing, and commercializing high-potential marketed pharmaceutical products and development-stage pharmaceutical product candidates. It has five marketed prescription pharmaceutical products and more than 25 programs in development at Fortress, at its majority-owned and majority-controlled partners, and at partners it founded and in which it holds significant minority ownership positions. Product candidates span six large-market areas, including oncology, rare diseases, and gene therapy, which allow the Company to create value while mitigating risk for shareholders.

Fortress Biotech lists on the NasdaqGS. The Company previously went by the name Coronado Biosciences, Inc. It changed its name to Fortress Biotech, Inc. in April of 2015. Established in 2006, Fortress Biotech is based in New York, New York.

Fortress Biotech has established partnerships with some of the world’s foremost academic research institutions and biopharmaceutical companies to maximize each opportunity to its full potential, including Alexion Pharmaceuticals, Inc., AstraZeneca, City of Hope, Fred Hutchinson Cancer Research Center, InvaGen Pharmaceuticals, Inc. (a subsidiary of Cipla Limited), St. Jude Children’s Research Hospital and Nationwide Children’s Hospital.

Fortress Biotech takes advantage of its extensive biopharmaceutical business and comprehensive drug development expertise to build a pipeline of commercial-stage products and development-stage product candidates, and to advance its products and pipeline as efficiently as possible with its partners. The Company’s present portfolio includes 5 revenue-generating dermatology products.

Last week, Fortress Biotech announced that Oncogenuity, Inc., a new Fortress partner company, entered into an exclusive global licensing agreement with Columbia University to develop novel oligonucleotides for the treatment of genetically driven cancers. The proprietary platform produces oligomers, now known as “ONCOlogues,” which are capable of binding gene sequences 1,000 times more effectively than complementary native DNA. The technology comes from the labs of Gary Schwartz, M.D., Division Chief, Hematology/Oncology, and Jeffrey Rothman, M.D., Ph.D., Assistant Professor of Medicine.

Oncogenuity is a biopharmaceutical company centered on the development and commercialization of ONCOlogues for the treatment of genetically driven cancers and coronaviruses. Oncogenuity’s lead asset targets a KRAS mutation, G12D.

Lindsay A. Rosenwald, M.D., Fortress Biotech’s Chairman, President and Chief Executive Officer, said, “We are excited to work with the excellent scientists and physicians at Columbia University again. Our last joint effort with Columbia University led to the formation of our partner company, Caelum Biosciences, Inc. (Caelum). Since formation, Caelum has raised approximately $60 million in development funding from a number of sources, with additional amounts available upon the satisfaction of certain milestones and will be initiating two registration clinical trials in the next several weeks…”

Fortress Biotech, Inc. (FBIO), closed Monday's trading session at $2.64, up 18.9189%, on 1,924,041 volume with 5,967 trades. The average volume for the last 3 months is 521,380 and the stock's 52-week low/high is $0.699999988/$2.18000006.

chart
n

Granada Gold Mine, Inc. (GBBFF)

Streetwise Reports, OTC Markets, Junior Mining Network, Stockchase, GuruFocus, 24hgold, Dividend Investor, YCharts, Investing News, Small Cap Power, AA Stocks, Online PR News, Morningstar, Seeking Alpha, Wallet Investor, The Stock Market Watch, Market Screener, Stockwatch, Nasdaq, Stockhouse, TradingView, Barchart, Proactive Investors, Smart Stock Trading Strategies, 4-Traders, and Investors Hangout reported previously on Granada Gold Mine, Inc. (GBBFF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Granada Gold Mine, Inc. is a junior mining and exploration company with Gold properties in the Province of Quebec. The Company’s current focus is the development and continued exploration of the Granada Property situated in the heart of the famous Abitibi Greenstone Belt and along the prolific "Cadillac Trend". This potential high tonnage, near-surface deposit is positioned 15 minutes from Rouyn-Noranda, Quebec.

Established in 1985, Granada Gold Mine is headquartered in Coquitlam, British Columbia. Its mining office is in Rouyn-Noranda. The Company previously went by the name Gold Bullion Development Corp. It changed its name to Granada Gold Mine, Inc. in January of 2017. The Company’s shares trade on the OTC Markets.

Approximately 120,000 meters of drilling has been completed so far on the Granada Gold Property. This drilling has focused chiefly on the extended LONG Bars zone that trends 2 kilometers east-west over a potential 5.5 kilometers of mineralized structure. The highly prolific Cadillac Break, the source of more than 75 million plus ounces of gold production in the past century, cuts through the north part of the Granada property.

Granada Gold Mine continues to advance the Granada Gold Property toward a high-grade production start with the aim of also increasing the already substantial NI-43-101 resources. The Granada Gold Property was first acquired by the Company in 2006. The Rouyn-Noranda airport offers easy access into the area and onto paved roads to the Granada Gold mine site. The area offers premier infrastructure and a good supply of skilled labour throughout the region.

In March, Granada Gold Mine announced it intersected two near-surface mineralized zones grading 11.53 grams per tonne gold over 2.9 meters at core length 65.85 – 68.75 meters and 2.61 grams per tonne over 24.7 meters at core length 25.5 – 50.2 meters in hole GB-19-SA. This drill hole is 77 meters to the south of GR-19-A, which intersected 11.45 grams per tonne over 33 meters core length (Granada news release dated January 9, 2020 ) in the latest drill program at its 100 percent-owned Granada gold deposit.

The A zone is 6 meters true width. The Company says that the continuing near-surface drilling program has started to unlock the excellent potential for defining further high-grade intersections within the recently explored two-kilometer LONG Bars Zone of the five-and-a-half-kilometer Granada Shear zone that trends East-West on the property.

Last week, Granada Gold Mine announced that it closed the first tranche of its non-brokered private placement financing raising gross proceeds of $818,000. The proceeds of the private placement will be used for surface exploration, trenching, and historical resampling of drill core on Granada Gold Mine's Granada Gold Property in Quebec and for general working capital purposes.

Granada Gold Mine, Inc. (GBBFF), closed Monday's trading session at $0.09445, off by 2.8292%, on 5,350 volume with 3 trades. The average volume for the last 3 months is 33,312 and the stock's 52-week low/high is $0.300000011/$3.29999995.

chart

Green Stream Holdings, Inc. (GSFI)

OTC PR Wire, Stock Wave, Market News First, OTC Markets, TipRanks, Financial Buzz, Stockopedia, Stockhouse, Insider Financial, CRWE World, Accesswire, GuruFocus, Stockwatch, Simply Wall St, Newsfilecorp, Market Screener, Seeking Alpha, Nasdaq, Barchart, Dividend Investor, GlobeNewswire, Investing.com, and InvestorsHub reported earlier on Green Stream Holdings, Inc. (GSFI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Green Stream Holdings, Inc. is a holding company of Green Stream Finance, Inc. It concentrates on currently unmet markets in the solar energy space via its unique proprietary solar product offerings, financed for customers through its public and private partnerships. Green Stream Finance, Inc. is a Wyoming-based corporation with satellite offices in Malibu, California and New York, New York and is presently licensed in California, Nevada, Arizona, Washington, New York, New Jersey, Massachusetts, New Mexico, Colorado, Hawaii, and Canada. Green Stream Holdings lists on the OTC Markets. The Company is headquartered in Pacific Palisades, California.

The Company's next-generation solar greenhouses are constructed and managed by Green Rain Solar, LLC, a Nevada-based division. The solar greenhouses use proprietary greenhouse technology and trademarked design developed by world-renowned architect Mr. Anthony Morali.

At present, Green Stream is targeting high-growth solar market segments for its advanced solar greenhouse and advanced solar battery products. It has a growing presence in the significantly underserved solar market in New York, New York. There, the Company is targeting 50,000 to 100,000 square feet of rooftop space for the installation of its solar panels.

Green Stream is looking to create key partnerships with major investment groups to capitalize on an array of innovative investment opportunities in the commercial solar energy markets. Its commitment is to becoming a major player in this important space.

Green Stream Finance is a community shared solar model where the benefits of solar energy creation can be shared among the residents of a community. The Company states that this model has proven extremely effective at "democratizing" the value of energy produced via rooftop or quasi-local solar farms by allowing local residents to purchase access to the energy proceeds through the local utility provider through customer contracts.

Green Rain Solar is the branded public face of the Green Stream Holdings ecosystem. It mainly engages in the construction of bespoke commercial solar projects and solar-powered greenhouses for rooftop agriculture or aquaponics (the symbiotic cultivation of aquatic life and vegetation). Green Rain installations will generate revenues via the sale of solar energy and also access to cultivation facilities within its greenhouses.

Today, Green Stream Holdings announced that it entered into an agreement that will permit it to take its initial step as part of its long-term plans to repurpose gas stations to make them more renewable energy friendly. It will construct solar car ports in three separate high traffic locations, owned by a well-known successful regional gas station owner/provider. The agreement calls for three locations in the North East at first, but is expected to expand to all locations post completion.

Green Stream Holdings, Inc. (GSFI), closed Monday's trading session at $0.60, off by 3.2258%, on 761,179 volume with 578 trades. The average volume for the last 3 months is 10,632 and the stock's 52-week low/high is $0.090999998/$0.531000018.

chart

Journey Energy, Inc. (JRNGF)

TipRanks, Capital Cube, OTC Markets, Trade Ideas, Market Seat, Barchart, Wallet Investor, Morningstar, PR Newswire, Nasdaq, Market Screener, Ceo.ca, Stockwatch, TradingView, Dividend Investor, MarketBeat, GuruFocus, Dividend.com, Tech Know Bits, and Stockhouse reported earlier on Journey Energy, Inc. (JRNGF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Journey Energy, Inc. engages in the exploration, development, and production of crude oil and natural gas in the Province of Alberta. Its emphasis is on oil-weighted operations in western Canada. The Company previously went by the name Sword Energy, Inc. It changed its corporate name to Journey Energy, Inc. in July of 2012. OTCQX-listed and founded in 2007, Journey Energy is based in Calgary, Alberta.

In July 2012, Journey Energy was created out of Sword Energy, Inc. From November 2012 to December 2013 it acquired Herronton and 10 additional minor acquisitions. Journey Energy has grown from 4,000 BOE/d at (47 percent liquids) to 8,500 BOE/d (49 percent liquids) via organic growth and accretive acquisitions over two years.

The Company’s strategy is to increase its production base through drilling on its existing core lands, implementing waterflood projects, and by executing on accretive acquisitions. It looks to optimize its legacy oil pools on existing lands via the application of best practices in horizontal drilling and, where feasible, with water floods. Additionally, Journey Energy is in the early phases of advancing development of an unconventional shale resource play in the oil window of the Duvernay, in the western shale basin of its central core area.

Journey Energy’s expertise in horizontal, multi-frac drilling and secondary recovery methods allows it to profitably acquire and develop large oil-in-place reservoirs fairways. In the Central Region it has (4,800 BOE/d; about 56 percent oil and NGLs) - Gilby-Duvernay, Crystal, Cherhill. In the South Region it has (5,200 BOE/d; about 38 percent oil and NGLs) - Matziwin, Skiff, Herronton. In the Resource Fairway it has shallow, low-risk development drilling in conventional oil pools. As of February 24, 2020, Journey Energy had total proved plus probable reserves of 57,546 thousand barrels of oil equivalent.

The global oil price took a sharp turn downward in mid-March with the onset of the COVID 19 pandemic and systematic shutdowns of worldwide economies. Journey Energy has shut-in roughly 1,500 boe/d (73 percent oil and NGL) of its production effective the first week of April. The Company continues to evaluate all of its oil properties as candidates for shut-in. Furthermore, the Company’s JV partner in the East Shale basin Duvernay resource play, has also shut in all production.

Journey Energy, Inc. (JRNGF), closed Monday's trading session at $0.4476, up 16.3807%, on 62,500 volume with 21 trades. The average volume for the last 3 months is 6,903 and the stock's 52-week low/high is $0.064999997/$0.309300005.

chart

Manhattan Bridge Capital, Inc. (LOAN)

Zacks, Stocktwits, StockNews, Equity Clock, Stockhouse, TeleTrader, InvestorsHub, Dividend Investor, ETF Channel, CSI Market, Simply Wall Street, Morningstar, GuruFocus, Market Screener, Investors Observer, Nasdaq, GlobeNewswire, YCharts, TMXmoney, Street Insider, Macrotrends, Dividend.com, Directors Talk Interviews, and Annual Reports reported earlier on Manhattan Bridge Capital, Inc. (LOAN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Manhattan Bridge Capital, Inc. is a real estate finance company listed on the NasdaqGS. It is a foremost leading hard money lender to professional real estate investors. The Company provides short-term secured financing to real estate investors in the New York metropolitan area. Established in 1989, Manhattan Bridge Capital has its corporate office in Great Neck, New York.

The Company offers short-term secured, non–banking loans (hard money loans) to real estate investors to fund their acquisition, renovation, rehabilitation, or improvement of properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida. Typical loans range from $300K - $600K. Every loan is secured by a first mortgage lien on a real estate.

Manhattan Bridge Capital focuses on three types of loans. These are loans to finance purchases and repairs for the purpose of quick sale; loans for small, new construction projects; and bridge loans to purchase small income producing properties. The loans are usually for a term of one year. The majority of the loans provide for receipt of interest only during the term of the loan and a balloon payment at the end of the term.

Recently, Manhattan Bridge Capital announced that Net Income for the three months ended March 31, 2020 was roughly $1,016,000, or $0.11 per basic and diluted share (based on roughly 9.7 million weighted-average outstanding common shares), versus about $1,121,000, or $0.12 per basic and diluted share (based on about 9.7 million weighted-average outstanding common shares) for the three months ended March 31, 2019. This represents a decrease of $105,000, or 9.4 percent.

The decrease is mainly because of the decrease in Revenue and the increase in General and Administrative Expenses, offset by the decrease in Interest Expense because of lower LIBOR rates. Total Revenues for the three months ended March 31, 2020 were approximately $1,711,000 versus approximately $1,788,000 for the three months ended March 31, 2019. This represents a decrease of $77,000, or 4.3 percent.

Last week, Manhattan Bridge Capital announced that its Board of Directors declared a quarterly dividend of $0.10 per share to be paid to all shareholders of record on July 10, 2020. The dividend will be paid on July 15, 2020.

Manhattan Bridge Capital, Inc. (LOAN), closed Monday's trading session at $4.78, up 9.3822%, on 86,252 volume with 433 trades. The average volume for the last 3 months is 54,193 and the stock's 52-week low/high is $0.032999999/$6.30000019.

chart

Tartisan Nickel Corp. (TTSRF)

Bull Market News, Serenity Stocks, Market Screener, Wallet Investor, Junior Mining Network, Investing News, Stockhouse, GuruFocus, InvestorX, TradingView, MarketWatch, Dividend Investor, Seeking Alpha, Morningstar, Simply Wall St, Markets.BusinessInsider, and Nasdaq reported previously on Tartisan Nickel Corp. (TTSRF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Tartisan Nickel Corp. is a mineral exploration and development company focused on base and precious metals in Canada and Peru. The Company owns 100 percent of the advanced stage Kenbridge Ni-Cu-(Co) Deposit in the Province of Ontario, through the acquisition of Canadian Arrow Mines Limited. The Company formerly went by the name Tartisan Resources Corp. It changed its name to Tartisan Nickel Corp. in February of 2018. Tartisan Nickel is headquartered in Toronto, Ontario. The Company also has an office in Lima, Peru.

The Kenbridge Deposit has an historical combined open-pit + underground, measured and indicated resource of 7.139 million tonnes at 0.62 percent nickel, 0.33 percent copper for a contained nickel resource of 97.8 million pounds with 47.8 million pounds of copper. The advanced stage deposit remains open in three directions, is equipped with a 623m deep shaft, and has never been mined. Further plans for Kenbridge include advancing the project through to feasibility and exploring the open mineralization at depth.

In Peru, Tartisan Nickel owns a 100 percent stake in the Don Pancho Zn-Pb-Ag and Ichuña Cu-Ag projects. It owns a 17 percent equity interest and 2 percent NSR (Net Smelter Return) in the La Victoria Au-Ag project through Eloro Resources Ltd. Eloro Resources is exploring the low-sulphidation epithermal La Victoria Gold/Silver Project in Ancash, Peru and the Iska-Iska project in Bolivia. Tartisan Nickel has been active for 10 years in Peru. The Company also owns a 100 percent interest in the Sill Lake Lead-Silver property situated in Vankoughnet Township, Ontario.

Concerning Don Pancho, US$1.5M has been spent on the property including bedrock mapping, induced polarization, and ground magnetics geophysics, and 2,021m of drilling. Pertaining to La Victoria, it is a 8,930ha property package positioned in a gold belt that includes Pierina, Lagunas Norte/Alto Chicama, La Arena, and Sta. Rosa that are large, low cost gold producers. It has first-rate infrastructure, with easy road access, abundant water, and an industrial power corridor 4.3km from the site.

This past March, Tartisan Nickel announced that it completed a Spectral Analysis Survey conducted by Aster Funds Ltd. over the Kenbridge Nickel-Copper-Cobalt Deposit, Atikwa Lake Area, Ontario. The survey covered the patented and single-cell mining claims that make up the historic land position that contains the Kenbridge Deposit and the surrounding area, identifying a number of new exploration targets for nickel, copper, cobalt, and also for potential gold occurrences. The Spectral Analysis Survey picked up several minerals implicit in the formation of nickel sulphide deposits, and potentially other kinds of deposits on the Kenbridge Property.

Tartisan Nickel Corp. (TTSRF), closed Monday's trading session at $0.0427, off by 31.129%, on 500 volume with 1 trade. The average volume for the last 3 months is 2,275 and the stock's 52-week low/high is $2.35999989/$14.2899999.

chart

Remark Holdings, Inc. (MARK)

Stocktwits, Zacks, Morningstar, Investors Observer, Barchart, YCharts, MacroTrends, Market Chameleon, Stockhouse, Investtech.com, Ready Ratios, CSI Market, InvestorsHub, Stockwatch, Barron’s, Newsheater, TradingView, Seeking Alpha, and Simply Wall St reported earlier on Remark Holdings, Inc. (MARK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Remark Holdings, Inc. is a diversified global technology company with leading artificial intelligence (AI) solutions and digital media properties. It chiefly concentrates on the development and deployment of AI-based solutions for businesses and software developers in many industries. In addition, Remark owns and operates digital media properties that deliver relevant, dynamic content.

The Company previously went by the name Remark Media, Inc. It changed its corporate name to Remark Holdings, Inc. in April of 2017. Established in 2006, Remark Holdings is based in Las Vegas, Nevada. It also has additional operations in Los Angeles, California, and in Beijing, Shanghai, Chengdu and Hangzhou, China.

Remark delivers an integrated suite of AI solutions. These solutions enable businesses and organizations to solve problems, lessen risk and deliver positive outcomes. Its easy-to-install AI products are being rolled out in a broad range of applications within the retail, financial, public safety, as well as workplace arenas.

Remark Holdings portfolio companies include Sharecare, Bikini.com, Banks.com, and Remark Entertainment. Sharecare’s mission is to help each person build a longer, better life through enabling health transformation at the individual, organizational and community level. Sharecare has a comprehensive platform. It enables people to go from assessment to action, and connect to the personalized information, evidence-based programs, benefits, community resources and health services they require.

Bikini.com is a lifestyle destination and curated collection. Banks.com answers questions that people have about money. Remark Entertainment delivers entertainment to China through six key pillars that cover Licensing, Talent, Social, Content Creation, Movie Copromotion and Content Production.

Earlier in March, Remark Holdings announced a major upgrade to its AI-based product offerings. KanKan AI improved its already-robust Smart Monitor technology by adding thermal detection, including body temperature detection. It also improved its facial recognition capability to include compliance with public sanitary regulations including the wearing of protective masks. This builds upon the successful technology platform that has already been deployed among students within the Hangzhou school systems for early flu detection.

The new and improved capabilities of KanKan AI's Smart Monitor technology allows for non-contact fever screening. This is more efficient and quicker than manual methods and which decreases the risk of cross contamination from human contact.

Remark Holdings, Inc. (MARK), closed Monday's trading session at $1.79, up 72.1154%, on 215,429,812 volume with 330,070 trades. The average volume for the last 3 months is 14,787,433 and the stock's 52-week low/high is $0.029999999/$0.141599997.

chart
Recently

Fearless Films, Inc. (FERL)

StockPrice, PennyStockBase, TipRanks, Stock Target Advisor, Simply Wall St, OTC Markets, Investors Observer, Stockhouse, Dividend Investor, Dividend.com, Nasdaq, Stockwatch, InvestorsHub, Stockopedia, last10k, TradingView, Wallet Investor, and PR Newswire reported beforehand on Fearless Films, Inc. (FERL), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Fearless Films, Inc. engages in the video and film production and distribution business. It is an independent full-service production company founded by award-winning actor, producer Mr. Victor Altomare. The Company produces first-rate entertainment with an edge. The service scope specializes in short film and feature film production in addition to script writing, copywriting, fulfillment and distribution. Fearless Films is headquartered in Concord, Ontario.

The Company has, since its inception, been on the map as a leading independent producer winning accolades at most major film festivals. Fearless Films has recognition for having a keen eye for emerging talent.

Fearless Films’ services include production elements, such as creative brief, editing, script writing, talent acquisition, voice overs, sound tracks, and graphical animation. It provides its services to directors and writers, and also for post-production and distribution/fulfillment.

At the end of October 2019, Fearless Films announced that it furthered discussions around its intent to acquire the rights to up to 12 movies from a library held by Mr. Victor Altomare, the President of Fearless Films, Inc., the Company's operating subsidiary. The Company chose The Lunatic as the first film to be selected for appraisal and final negotiation.

The Lunatic premiered at the Montreal Film festival, won the bronze award in Houston and won the Gold award at the Yorkton, Saskatchewan festival. The movie starred Victor Altomare, Lazar, Jennifer Dale, as well as boxing great George Chuvalo. It was produced by Victor Altomare and directed by Robert Longo.

In December, Fearless Films, Inc. announced that it entered in a $5 million equity financing facility with Crown Bridge Partners, LLC. These funds will be used to develop the Company's film assets by providing capital to complete film projects and to enable Fearless Films to participate as a partner with other production firms. In addition, this facility will be used to provide capital for general corporate purposes.

Fearless Films, Inc. (FERL), closed Monday's trading session at $0.112, up 49.1345%, on 6,000 volume with 2 trades. The average volume for the last 3 months is 4,322 and the stock's 52-week low/high is $0.002099999/$0.028799999.

chart

One World Pharma, Inc. (OWPC)

PennyStockBase, Stocks News Feed, Simply Wall St, Daily Marijuana Observer, NewMediaWire, PR Newswire, Street Insider, Dividend Investor, Investors Hangout, Oil and Gas 360, TradingView, Seeking Alpha, Stockwatch, Stockopedia, GlobeNewswire, and InvestorsHub reported previously on One World Pharma, Inc. (OWPC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

One World Pharma, Inc. is the U.S. parent company of One World Pharma S.A.S, which is a fully licensed cannabis and hemp producer with offices and operations in Bogota and Popayan, Colombia. The Company’s intention is to supply the highest quality cannabis and hemp derivatives in crude oil, distillate and isolate forms with industrial scale production to serve worldwide cannabis demand. One World Pharma products will be produced and tested to GMP and ISO standards. The Company lists on the OTC Markets. It has its U.S. office in Las Vegas, Nevada.

In 2018, One World Pharma planted its first crop of cannabis at its cultivation site in Popayan, Colombia, for research purposes. The Company expects to commence harvesting commercially in Q4 of this year. One World Pharma uses their wide-ranging knowledge and research of the cannabis plant to cultivate specific strains from around the world - with 25 registered strains at ICA (Instituto Colombiano Agropecuario) and dozens more awaiting approval.

In essence, One World Pharma is a large-scale producer of high-quality cannabis and hemp products for the medical and commercial markets. The Company has more cultivation facilities under contract in addition to its Popayan, Colombia (135KM south of Cali) facility. One World Pharma has been granted four licenses for the cultivation of Non-Psychoactive (Low) THC, Psychoactive (High) THC, and the manufacture of cannabis derivatives and seeds.

This past April, One World Pharma announced it was granted permission by ICA to start cultivating 13 proprietary high THC cannabis strains and 2 high CBD strains. The approval greatly speeds up the Company’s efforts as one of the first cultivators of scale in the highly desirable Colombian production environment.

One World Pharma’s next step will be to put these strains through characterization tests to confirm their genetic attributes, in particular local environments. Upon successful characterization tests, the Company will register these cannabis strains and genetics and be in a position to cultivate for commercial purposes. It anticipates getting permission to put additional strains through this process during 2019.

In May, One World Pharma announced that it entered into its first seed sale agreement in Colombia with Mr. Kevin Steven Ocampo Prieto of Bogota. Via this long term, evergreen agreement, the Company agreed to provide Mr. Prieto with seeds of its non-psychoactive cannabis strains that are in the registration procedure for the national register of commercial cultivars of the ICA.

One World Pharma, Inc. (OWPC), closed Monday's trading session at $0.335, up 50.9009%, on 650 volume with 7 trades. The average volume for the last 3 months is 19,258 and the stock's 52-week low/high is $0.000000999/$0.002249999.

chart

Trutankless, Inc. (TKLS)

Amigo Bulls, Dividend Investor, Market Screener, OTC Markets, Street Insider, Last10k, MarketWatch, Investors Hangout, Insider Tracking, Stocks News Feed, Oilandgas360, InvestorsHub, PR Newswire, The Street, Trading View, Canadian Insider, Zacks, 4-Traders, Morningstar, GuruFocus, Wallet Investor, Barchart, Simply Wall St, and Capital Cube reported on Trutankless, Inc. (TKLS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Trutankless, Inc. is a technology-driven developer of accessible, next-generation home automation and efficiency systems. Its main products are a line of electric tankless water heaters, which exceed traditional tank water heaters in energy efficiency, output, dependability and environmental sustainability. Established in 2008, Trutankless has its corporate headquarters in Scottsdale, Arizona. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Fundamentally, the Company’s vision is to modernize tankless water heating through promoting energy conservation and long term savings with its pioneering product for the benefit of homeowners, service professionals and consumers. Regarding the Trutankless Smart Unit, it has a Touchscreen LCD display with Wi-Fi connectivity, built-in safety features, adjustable power management and temperature settings. It has built in breakers for added safety and custom stainless alloy elements that operate more efficiently.

The custom heat exchanger uses patent pending Velix technology and ceramic thermal insulation. The flow meter produces hot water at a consistent temperature within 1 degree.

Trutankless sells its products to plumbing wholesale distributors and dealers throughout the United States. Working together with its manufacturing partner, Taiwan-based, SINBON Electronics, in Q3-2018 Trutankless completed phase one of its new manufacturing capabilities. This considerably expands the Company’s volume capacity to a thousand units per month.

Trutankless expanded its national active wholesaler mark from 165 locations at the start of 2018 to more than 1,000 wholesaler locations by the end of the year. The Company has national partnerships with groups such as Mr. Rooter, and relationships with Benjamin Franklin and RotoRooter.

Trutankless established new partnerships with a number of nationally recognized plumbing and installation organizations including Service Experts, and numerous dominant regional companies in target markets. This year, the Company’s goal is to focus additional attention and resources to the national launch of its wholesale market footprint, working to maintain the thrust of the sales volume in this channel.

Trutankless, Inc. (TKLS), closed Monday's trading session at $0.256, up 82.8571%, on 63,500 volume with 6 trades. The average volume for the last 3 months is 15,587 and the stock's 52-week low/high is $0.200000002/$7.59049987.

chart

Protalex,  Inc. (PRTX)

StreetInsider, Zacks, TopStockAnalysts, and OTCPicks reported on Protalex,  Inc. (PRTX), and we highlight the Company as well, here at the QualityStocks Daily Newsletter. 

Protalex,  Inc.  is a clinical-stage Biopharmaceutical Company based in Florham Park, New Jersey. Its emphasis is on the development of a class of drugs for treating autoimmune and inflammatory diseases. These include RA  (Rheumatoid Arthritis) and ITP  (Immune Thrombocytopenia). The Company’s lead product is PRTX-100. This is a formulation of a proprietary, highly purified form of Staphylococcal Protein A, which is an immunomodulatory protein produced by bacteria.  Protalex’s shares trade on the OTC Markets Group’s OTCQB.

Rheumatoid arthritis (RA) is an autoimmune disease. RA is a disorder in which the body’s immune system mistakenly attacks the joints. Immune Thrombocytopenia (ITP) is a blood disorder. ITP can result in easy or excessive bleeding and bruising because of the body’s inability to form blood clots.

Pre-clinical data indicate that PRTX-100 may have the potential to treat ITP through reducing the immune-mediated destruction of the platelets. Protalex has open IND’s for the treatment of RA and ITP in the United States, and in Europe, an open IMPD for ITP.

Protalex’s PRTX-100 can  (at very low concentrations) bind to human B-lymphocytes and macrophages and to modulate immune processes. PRTX-100 has been granted Orphan Drug Designation in the United States and in Europe for the treatment of ITP. This status provides commercial exclusivity benefits, tax credits for certain research, potential research grants and a waiver of the New Drug Application user fee in the United States. Currently, it is the subject of clinical studies in the U.S. and Europe.  

PRTX-100 is administered as a short intravenous infusion.  The following patents have been granted for PRTX-100:  U.S. Patent No. 9,370,552 (‘552 patent) is a continuation patent to initial U.S. patent No. 7,211,258 (Protein A compositions and methods of use) filed in 2002 and issued with method of treatment claims for RA, juvenile RA, and systemic lupus erythematosus (SLE). The ‘552 patent expands the method of treatment of PRTX-100 to include type 1 diabetes.  

European Patents No. 2,570,136 and 2,206,511 (national patents in place in France, Germany, Italy, Spain, Switzerland, and the UK) includes composition claims relating to numerous autoimmune diseases (RA, ITP, juvenile RA, psoriasis, myasthenia gravis) and dosage expansion. 

Canadian patents No. 2,894,098 and No. 2,481,282 comprise method of treatment claims relating to RA and SLE.  Japanese patent No. 5,523,796 claims compositions for treating psoriasis, scleroderma, Crohn’s Disease, myasthenia gravis, ulcerative colitis, psoriatic arthritis, as well as pemphigus vulgaris.

Recently, Protalex announced that following a planned interim analysis of data from the fourth dose cohort of its European Phase 1b study of PRTX-100 (PRTX-100-203 Study) in adults with persistent/chronic Immune Thrombocytopenia (ITP), it initiated enrollment in the fifth and highest dose cohort of this dose-escalating study.

The first patient in the final cohort was recently dosed in the United Kingdom at 24 micrograms/kg. This the highest dose of PRTX-100 used in any clinical trial to date. One of the three patients treated in the fourth dose cohort (18 micrograms/kg) attained a protocol defined platelet response.

Protalex,  Inc. (PRTX), closed Monday's trading session at $0.0055, up 161.9048%, on 17,030 volume with 2 trades. The average volume for the last 3 months is 5,209 and the stock's 52-week low/high is $0.100000001/$18.5799999.

chart

Cell Source, Inc. (CLCS)

InvestorsHub and OTC Markets reported on Cell Source, Inc. (CLCS), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter. 

Cell Source, Inc. is a Biotechnology Company listed on the OTC Markets Group’s OTCQB. The Company concentrates on developing cell therapy treatments established on immunotherapy and regenerative medicine. Its principal product is the Veto-Cell immune system management technology. Cell Source has its headquarters in New York, New York.

Cell Source’s Veto-Cell immune system management technology is an immune tolerance biotechnology. It enables the selective blocking of immune responses. The Company’s Veto-Cell technology is utilized in varied applications. These include bone marrow transplantation, veto-cell in transplantation, anti-cancer, and also non-malignant diseases. 

The patented Veto-Cell technology addresses one of the most fundamental challenges in human immunology. This challenge is: how to tune immune response so that it tolerates specific “desirable” foreign cells while continuing to attack all other potential threats. 

Veto cells disable the attack of the immune system on the bone marrow transplantation (BMT) only, without other side effects. The Veto cells act as “decoys” that attract, and then kill, the T-cell clones directed at the transplant.

The Veto cells continue “on guard” in the body for lengthy periods of time to further limit rejection. Therefore, the transplantation is accepted by the body without compromising the rest of the immune system. 

The principal goal in developing Veto Cells is to have a meaningful and potentially widespread  impact on the field of bone marrow and major organ transplantation. In addition, Veto Cells can be combined with other cell therapy treatments to improve their effectiveness. In preclinical studies, Veto Cells have been shown to increase efficacy and persistence of genetically modified cells.

Along with its Veto Cells technology, Cell Source has its Megadose Drug Combination technology. The method of action includes stem cells overcoming rejection by outnumbering immune rejecting cells, and drugs reduce the need for immune suppression.

The Company has a substantial Intellectual Property (IP) Portfolio, exclusively licensed to it from the Weizmann Institute of Science by way of Yeda Research and Development Company Ltd. covering Dr. Yair Reisner’s technologies.

Dr. Yair Reisner is former Chairman of the Department of Immunology of Israel’s Weizmann Institute of Science. He pioneered “mismatched” BMT (partial versus full donor/recipient match) with his patented “Megadose” cell therapy treatment.

In essence, Cell Source’s corporate  mission is to transform the fields of transplantation, cancer treatment, and reversal of vital organ disease, using its pioneering immune tolerance and organ regeneration technologies.

Cell Source, Inc. (CLCS), closed Monday's trading session at $0.75, up 47.0588%, on 4,430 volume with 5 trades. The average volume for the last 3 months is 2,105 and the stock's 52-week low/high is $0.059999998/$7.875.

chart

Dais Analytic Corp. (DLYT)

HotOTC, SmallCapVoice, CoolPennyStocks, MadPennyStocks, StockEgg, StockRich, Stockpalooza, Money Morning, Penny Stock Rumble, FeedBlitz, M2 Communications, SmallCap Pulse, BullRally,  PennyInvest, PennyStockVille, and Greenbackers  reported  earlier on Dais Analytic Corp. (DLYT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.  

Dais Analytic Corp sells its industry-changing nanomaterial technology into the global water, air, and energy markets. A commercial nanotechnology materials enterprise, the Company provides nanotechnology-based applications for heating & cooling, water treatment, and energy storage. It is commercializing its unique Aqualyte™ family of nano-structured materials and processes centering on disruptive air, energy, and water applications. Dais Analytic is headquartered in Odessa, Florida.  

The uses of the Aqualyte™ family of nano-structured materials and processes include ConsERV™. This is a commercially available engineered energy recovery ventilator (a heating, ventilation, and air conditioning (HVAC) product). 

In addition, the uses include NanoAir™. This is an early beta-stage water-based, no fluorocarbon producing refrigerant cooling cycle.  Uses also include NanoClear™. This is an early beta-stage method for treating contaminated water to provide 1,000 times cleaner potable water.

The NanoClear™ process has consistently shown that Dais Analytic’s novel Aqualyte® material can separate most contaminants from water, realizing almost 'parts per billion' clean product water with little or no fouling of the vital membrane component. 

NanoClear™ is a leading-edege water cleaning architecture enabled by the features in the Company’s nanomaterial - Aqualyte™. The NanoClear™ product line is a critical application in purifying contaminated water having high salt content, low pH, or where the requirement for Total Dissolved Solid (TDS) in the product water is 10 or less. 

Furthermore uses include NanoCAP™. Dais indicates that NanoCAP™ holds promise to use the Aqualyte™ family to form a disruptive, non-chemical, energy-storage device (an ultra-capacitor) when completed for use in transportation, renewable energy, and also 'smart grid' configurations.

This past summer, Dais Analytic announced it signed a 7 year, non-exclusive agreement with the Menred Group, Zhejiang province, China, to provide its Aqualyte moisture transfer nanomaterial for use in a newer line of Menred energy recovery ventilators (ERV) to sell into the increasing Chinese heating, ventilation and air conditioning (HVAC) market.

Energy Recovery Ventilators are used in association with HVAC equipment to save capital and operating costs. This is while improving the quality of life for the building's occupants.

High effectiveness ERVs, such as ConsERV™ or Menred Group's new line of ERVs to be built utilizing Dais Analytic's Aqualyte nanomaterial, enable architects and engineers to design buildings with considerable volumes of filtered, preconditioned supply air.

Mr. Brian Johnson Dais Analytic’s Chief Technology Officer, said in July 2017, "Dais' ConsERV™ has long been a leader in this field as established by our Air-Conditioning, Heating and Refrigeration Institute (AHRI) certified performance -- along with other similar ratings from 3rd party rating company's worldwide. Our Aqualyte™ nanomaterial, now in its 4th generation, drives this performance and we are excited about working with Menred to bring a new series of ERVs with Aqualyte to the growing Chinese ERV market."

Dais Analytic Corp. (DLYT), closed Monday's trading session at $0.3997, up 224.9594%, on 3,010 volume with 5 trades. The average volume for the last 3 months is 785 and the stock's 52-week low/high is $0.095600001/$2.60500001.

chart

The QualityStocks Company Corner

Champignon Brands Inc. (FWB: 496) (CSE: SHRM) (OTC: SHRMF)

The QualityStocks Daily Newsletter would like to spotlight Champignon Brands Inc. (CSE: SHRM).

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences Company with an emphasis on ketamine and psychedelic medicine, today announced its appointment of Dr. Roger McIntyre as its Chief Executive Officer. Among several additional roles, Dr. McIntyre is a Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto. To view the full press release, visit http://cnw.fm/E5z0a. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. When state governments started ordering lockdowns and issuing stay at home orders, the economy took a severe hit. So severe, in fact, that the federal government passed a $2 trillion emergency relief package. Qualified citizens, along with small businesses, would receive cash payments and business loans to help them weather the financial storm.

Champignon Brands Inc. (FWB: 496) (CSE: SHRM) (OTC: SHRMF) is a research-driven company specializing in the formulation and distribution of a suite of artisanal mushroom health supplements. Dedicated to revolutionizing conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, Champignon’s expanding portfolio is crafted with the health-conscious consumer in mind.

Headquartered in Vancouver, British Columbia, Champignon’s team aims to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health care and pharmaceutical products.

Brands

Champignon’s mushroom-derived consumer packaged goods (CPGs) portfolio includes its flagship brand, Vitality Superteas. Each carefully curated Vitality Supertea formulation was developed with the intent of helping individuals enhance and enrich their wellbeing one cup of mushroom-infused tea at a time.

Also in the portfolio are Nourish Force Supertea, a blend of Reishi Ryobus Tea Mix; Mighty Recharge Supertea, created with Lions Mane Tropical Green Ginseng Tea Mix; and Brain Enhance Supertea, a blend of Cordycep Hibiscus and Berries Tea Mix – all of which are formulated with organic ingredients and chosen for their ability to provide unique health and performance benefits.

Champignon’s flagship e-commerce store, VitalitySuperTeas.com, takes advantage of the burgeoning craft mushroom vertical space with a selection of mushroom-infused teas and accessories.

Functional Mushroom Market

Demand for consumer products infused with the nutritional and bioactive benefits of mushrooms is fueling a global market projected to reach $34.3 billion by 2024, growing at a compound annual growth rate of 8.04% from 2019-2024 (ResearchandMarkets), with Europe seen as the fastest growth leader.

According to the market study, in highest demand are products infused with Reishi – a traditional Chinese medicine also known as the “Elixer of Life” and “Mushroom of Immortality – Lions Mane and Cordyceps, followed by other types of medicinal mushrooms.

Advances in Legalization

Legalization of psychedelics for use in medicine is gaining momentum across the United States. Denver, Colorado, and Oakland and Santa Cruz, California, have decriminalized the use of psilocybin, the psychedelic molecule found in various mushrooms, while movements for legalization are gaining ground in Oregon and Iowa, among others. Decriminalize California recently teamed up with the Beckley Foundation to replicate Oakland’s success of decriminalization throughout the state of California.

An increasing number of researchers are turning their attention toward the study of psilocybin as a means to treat otherwise untreatable illnesses. The molecule’s ability to provide landmark treatment options for depression, post-traumatic stress disorder (PTSD), migraines and addiction is gaining widespread acceptance among medical professionals, unicorn investors and accredited institutions.

Potential Applications

Historical data and new scientific studies suggest therapeutic benefits of psychedelics in many areas, including drug addiction, alcoholism, depression, migraines, smoking cessation and post-traumatic stress disorder (PTSD).

The market potential in these areas are significant. To reference just one of the above conditions, the mental health arena has been frequently neglected over the last 30 years, though new research is beginning to further reinforce that psychedelic compounds have the potential to produce more effective treatments than what is currently available.

According to the World Health Organization, 25% of the world’s populous will be afflicted by mental health and/or neurological disorders. Presently, approximately 450 million people currently suffer from such conditions, placing mental disorders among the leading causes of ill-health, productive loss and disability worldwide.

Additionally, PTSD affects approximately 2.2% of the U.S. population; 7.7 million people will have PTSD at some point in their lives. Recent published studies have demonstrated the safety and efficacy of certain psychedelics when administered in a medically supervised and monitored approach.
A renaissance in alternative medicines is emerging, and Champignon has set in motion its strategy to become a key player.

2020 Stealth IP Strategy

Champignon plans to biosynthesize psilocybin within the first three months of conducting laboratory experiments, with the objective of achieving optimized and scaled production of pharmaceutical-grade psilocybin for deployment in clinical settings. This strategy includes:

  • Alternative medicine (psilocybin) IP aggregation
  • Development of cGMP formulations of bioactive compounds extracted from plants and Fungi
  • Drafting of benchmark SOPs (Standard Operating Procedures)
  • Patient aggregation, focusing on veterans

Defining a New Asset Class: Psychedelic-Inspired Medicines

In the third quarter of 2020, Champignon – through clinical trials, a compelling IP portfolio and clinical pipeline and drug development platform – plans to advance its pursuit of treatments underpinned by psychedelic substances. This strategy is broken down into two ties:

  • Non-Hallucinogenic Medicines
    • Microdosing Psilocybin/LSD
    • MDMA, commonly known as ecstasy
  • Hallucinogenic Medicines
    • Psilocybin high dose
    • LSD high dose

Partnerships

Companies worldwide are beginning to incorporate functional mushrooms into their product offerings, taking advantage of growing consumer awareness of known health benefits of the ingredients found in mushrooms.

Champignon in November 2019 entered into a distribution partnership with Eurolife Brands Inc. (CSE: EURO), a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide through a data-driven CBD marketplace supported by exclusive and unbiased physician-backed cannabis education and detailed consumer analytics. Under the agreement, Champignon’s branded products are integrated into Eurolife’s e-commerce platform, along with potential distribution opportunities in select brick-and-mortar retail locations in Europe.

Champignon also has an R&D/production formulation agreement with Drip Coffee Social Ltd., located in Nanaimo, British Columbia, which calls for the infusion of Champignon’s proprietary mushroom extract blend into a suite of cold brew coffee products and signature in-house formulations.

Leadership

Gareth Birdsall, CEO, Corporate Secretary and Director
Gareth Birdsall has more than seven years of experience working in diverse agricultural roles such as the cultivation of various fungi, in particular Cordycepes, Reishi, Lions Mane and Chaga. He is an attendee of the British Columbia Institute of Technology, studying marketing management and finance.

Steven Brohman, CPA, CFO
Steven Brohman has more than 10 years of experience working in a variety of roles with public and private companies. He has had extensive training in the audit of publicly traded companies on the TXS, TSX Venture Exchange and OTC markets, and serves as CFO and director of various public and private companies. Brohman has a bachelor’s degree of business administration and obtained his Chartered Professional Accountant designation.

Jerry Habuda, Director
Jerry Habuda brings to Champignon over 35 years of expertise in law enforcement and specialized units. From 1977 to 2012, he served as a police officer with the Toronto Police Department. During his tenure, he was assigned to the Major Crimes Unit, investigating robberies and home invasions. He was assigned to patrol the Toronto Community Housing projects at Jane/Finch to control drug trafficking and gun violence. Habuda was with the Warrant Unit where he tracked down and arrested wanted criminals. From 1993-1997, he was assigned to the Northwest Drug Squad on undercover and surveillance work, executing narcotic search warrants. Between 2002 and 2004, Habuda headed the Street Violence Task Force, a special unit designed to curb gun and drug violence that was terrorizing the city at the time.

Champignon Brands Inc. (CSE: SHRMF), closed Monday's trading session at $0.71, up 0.15517%, on 416,148 volume with 206 trades. The average volume for the last 3 months is 241,947 and the stock's 52-week low/high is $2.70000004/$11.6000003.

Recent News

chart

PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA)

The QualityStocks Daily Newsletter would like to spotlight PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA).

The future of auto sales is online, and PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) is launching an innovative digital advertising campaign to offer its platform enabling virtual transactions to consumers and automotive dealers across the United States. The platform will allow them to sell, buy, lease, auction and finance vehicles irrespective of their location, including within any form of video.

A Better Way to Connect and Acquire Vehicles

PowerBand’s mission is to create an online, consumer-directed marketplace that streamlines the interactions among all participants in the automotive industry. It transforms today’s antiquated business model with speed, transparency, access to information and ease of use for consumers and dealers.

Consumers can easily connect with new sources to buy vehicles, network with motivated buyers and sellers, maximize their trade-in values, improve their customer experience. PowerBand’s standardized system and transaction process also increase efficiencies and benefits with hands-on, process-driven, in-store training and support.

Through internal development, acquisitions, joint ventures and strategic partnerships, PowerBand is developing solutions for consumers, dealers, manufacturers, commercial customers and lenders that are poised to transform the trillion-dollar U.S. automotive industry.

The PowerBand Auto Platform

PowerBand’s transaction platform was developed by a team of experienced automotive, technology and finance experts, and has been refined through years of operational experience. Built on the core belief that the consumer prefers to primarily conduct automotive transactions online and avoid interactions with unnecessary middlemen, PowerBand’s product solutions include:

  • Leasing: PowerBand is currently licensed in 33 U.S. states via a majority interest in MUSA Auto Finance LLC, an advanced online leasing technology platform that has transformed the new and used vehicle leasing industry. A partnership with Tesla was recently finalized, making MUSA the only approved, non-captive lease partner for Tesla in the U.S.
  • Inventory and Financing: A partnership with RouteOne LLC, a leading financial platform founded in 2002 by Ally Financial, Ford Motor Credit Co., TD Auto Finance and Toyota Financial Services, allows access to a network of more than 18,000 dealerships and 1,400 financing sources.
  • Auction Platform: PowerBand and its joint-venture partner, D2D Auto Auctions, are developing a direct consumer-to-dealer and a consumer-to-consumer automotive portal, which will provide an innovative alternative to physical dealership and auction locations.
  • LiveNet Auction: An online platform portal that allows dealers to create instant live vehicle auctions to a vast network of the industry’s top used vehicle buyers.
  • MarketPlace Auction: An online listing auction site for buying and selling automotive inventory – ideal for dealers, fleet, OEM and rental companies.
  • Used Vehicle Inspections: An LOI agreement with TÜV NORD Mobility Inc., a German-based global leader in vehicle inspections operating in more than 70 countries, will provide the most comprehensive, certified vehicle inspection reports available in North America. Appointments booked within the platform can be performed nearly anywhere.
  • Product Development: PowerBand’s comprehensive consumer solution, Driveaway, will be a fully transactional consumer marketplace where dealers and consumers can buy, sell, trade-in and finance vehicles, often in seconds, from the comfort of their home.

Automotive’s Growing Markets

The automotive dealership and commercial fleet vehicle auction industry is a $100-billion sector with more than 40 million used vehicles transacted in the U.S. each year. Of those, ten million are sold through auctions. From 2013 to 2017, the growth of online-only auctions far outpaced physical auctions, growing at a 33% compound annual growth rate compared to 2% CAGR at physical auctions.

Automotive leasing is another large, growing and fragmented market, generating approximately $120-billion in annual revenue. As a percentage of vehicle sales, leasing reached 30% in 2018, up from 21% in 2012, and is seen as a substantial opportunity for PowerBand and MUSA Auto Finance. Using proprietary technology and by focusing on high-quality, credit-worthy customers, MUSA grew its automotive lease originations to $182 million.

Disrupting Auto Leasing with MUSA

Legacy solutions are complicated, expensive and slow at processing leases. MUSA’s first-of-its-kind technology platform eliminates third-party decisions and the human capital required in the underwriting process. MUSA’s platform navigates the entire customer experience – underwriting, funding and the delivery process – within minutes. Leases can be approved in seconds.

PowerBand’s acquisition of MUSA brings together two leading-edge companies with the vision to become a one-stop platform for the entire vehicle purchase lifecycle.

Experienced Leadership

PowerBand is led by a collection of automotive veterans with a passion to collectively and positively impact the industry.

  • Kelly Jennings, president and CEO, is the founder of PowerBand Solutions and a franchise dealer owner/operator with more than 27 years of automotive experience. Jennings received General Motor’s Triple Crown Award, Ford Motor Company President’s Award and Honda Canada’s Excellence Award.
  • Darrin Swenson, COO of PowerBand and D2D Auto Auctions/Hunt Automotive Group, has more than 25 years of automotive/auction experience.
  • Jeff Morgan, CEO MUSA, holds over 25 years of experience in the auto finance sector.

 

PowerBand Solutions Inc. (OTCQB: PWWBF), closed Monday's trading session at $0.085, up 1.5532%, on 100,500 volume with 11 trades. The average volume for the last 3 months is 24,438 and the stock's 52-week low/high is $0.600600004/$4.48999977.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

A third-party April 2020 report conducted by Global Small Cap Research has concluded that investors should closely watch Sugarmade Inc. (OTCQB: SGMD), “as it has before it a significant business opportunity.” The report also noted that Sugarmade’s public status can be leveraged to gain advantage in a turbulent industry that has been significantly impacted by COVID-19 (http://cnw.fm/W1a82). Also today, CannabisNewsWire released a report on the company detailing how its CEO, Jimmy Chan, as well as the CEO of Budcars, Clinton Walker, were featured on The Stock Day Podcast hosted by Everett Jolly. To view the full press release, visit http://cnw.fm/vc4gQ

Sugarmade, Inc. (SGMD) is headquartered in Monrovia, California, where the company recognizes new opportunities in the cannabis delivery space and in the market for supplies to the quick-service restaurant industry – both of which have fast-changing dynamics due to the recent outbreak of coronavirus in the United States.

The Coronavirus Cannabis Boom Market

Retailers across the nation are closing their doors and curtailing operations due to the coronavirus pandemic, inherently pinching sales. In the California cannabis sector, however, business has never been better – especially relative to home delivery.

California’s cannabis industry continues to operate, and media reports reveal booming cannabis sales as the state’s citizens stay home to wait out current events. The Los Angeles Times recently published the headline, “Marijuana Sales on Fire amid Virus Outbreak; New York Post “Cannabis sales hit new highs”; USA Today “American Stock Up on Pot” Fox News “California marijuana sales surge”; and ABC News Cannabis Shops thrive in coronavirus pandemic.

The state of California benefits from the ultra-high taxes paid by the highly regulated cannabis industry, and has thus deemed cannabis companies as “essential” businesses, allowing for full operations to continue. While pot shops are seeing strong foot traffic, the real growth action is in-home delivery as consumers seek to embrace social distancing. Many delivery operators are reporting difficulty in meeting demand with sales growth of up to 10% sequentially each week. It is certainly a boom time for the industry.

Sugarmade Growth Strategy

Recognizing new investment and operational opportunities within California’s cannabis market, Sugarmade is strategizing to take advantage of opportunity specifically in delivery services (non-storefront retailer), manufacturing via co-branding, and selective genetic cultivation. The company is taking a highly selective approach, targeting only the best of these opportunities for company growth.

In line with this strategy is northern California delivery service Budcars, in which Sugarmade owns a 40% interest and an option to gain a controlling interest. Budcars connects consumers with premium products sourced from top-tier farms and extractors, offering a curated menu of fully compliant cannabis products. The company maintains a competitive advantage by sourcing premium cannabis offerings and same-day delivery. In addition to maintaining its own cars, California licenses, and fulfillment center, Budcar orders its premium products in bulk at lower prices, enabling the company to rein in costs and maintain competitive pricing for its customers. Currently serving major communities within the metropolitan area of Sacramento, Budcars plans to continue the expansion of the company’s delivery reach.

Sugarmade plans to continue its expansion into burgeoning new sectors of the cannabis market through the following avenues:

  • Geographic expansion of Budcars delivery scope
  • New delivery geographies
  • Cannabis cultivation as a key component of a hybrid vertical integration strategy
  • Product technology expansion—including products containing exotic and lesser-known cannabinoids

 

Diversified Portfolio

Sugarmade has positive market exposure to cannabis delivery, as well as to the restaurant industry, at a time when these businesses are being force to move toward take-out and delivery models in order to survive.

The company has various business operations in diverse marketplaces, including food, safe packaging and sanitary supplies for various industries, and agricultural supplies. Sugarmade entered the industrial hemp and CBD space by investing in Hempistry, Inc., a privately held Nevada corporation. Hempistry began planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 5,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3% of THC, the psychoactive ingredient found in cannabis.

CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high-quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30%-40% of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Market Opportunity

There is little doubt among industry participants, and recently confirmed by Forbes, that California is the single largest cannabis market in the world. The state is expected to produce more than $3.5 billion in cannabis sales during 2020, with growth topping 23% annually. The global industrial hemp market size was estimated at $4.71 billion in 2019 and is expected to register a revenue-based CAGR of 15.8% over the forecast period of 2016-2027, according to Grandview Research. Market growth drivers include the 2018 Farm Bill and society’s increasing knowledge of the benefits of hemp products.

Overall industry growth is great, but specific vertical sector growth is even better. Cannabis delivery is clearly the fastest growing sector of the marketplace and with coronavirus fears the already robust growth rate has accelerated.

Sugarmade seems to be in the right industry at the right time in history.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick-service restaurant industry, which merged with Sugarmade in 2014.

Dedicated to getting the highest caliber of THC and CBD to its customers’ door, the company’s priority is to ensure that they receive the highest quality cannabis product free from logistical hassles. Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed Monday's trading session at $0.0026, up 4.00%, on 13,767,976 volume with 174 trades. The average volume for the last 3 months is 20,222,970 and the stock's 52-week low/high is $0.221/$0.998300015.

Recent News

chart

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX (NASDAQ: SRAX), a digital marketing and consumer data management technology company, today released a Mother’s Day research study with Publicis Groupe, one of the largest marketing and communications companies in the world. According to the update, Publicis Groupe activated Lightning Insights and surveyed BIGtoken users across its panel of millions of consumers to examine the ways in which consumers purchased and celebrated Mother's Day. Per the study, 84% of respondents celebrated Mother’s Day in some way this year, with 49% having hosted a virtual gathering, 68% sending a gift, gift card or food, and 49% purchasing items online for the holiday. To view the full press release, visit http://nnw.fm/IHce4

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Monday's trading session at $1.85, off by 1.5957%, on 58,741 volume with 272 trades. The average volume for the last 3 months is 57,001 and the stock's 52-week low/high is $0.124389998/$0.522899985.

Recent News

chart

InsuraGuest Technologies, Inc. (TSX.V: ISGI)

The QualityStocks Daily Newsletter would like to spotlight InsuraGuest Technologies, Inc. (TSX.V: ISGI).

It took a while, but insurtech is now giving fintech a run for its money. Slow off the starting block, innovation in the insurance industry is currently outpacing digital developments in banking, payments, and other financial technologies. As a result, traditional insurers are turning to companies, such as InsuraGuest Technologies Inc. (TSX.V: ISGI), that offer cutting-edge ideas and solutions to revamp antiquated business models and systems. Consequently, InsuraGuest plans to increase its range of services to meet the growing demand for insurtech solutions. Digitizing insurance services is widely expected to reduce operating costs and increase customer satisfaction during the sign-up, renewal and claims processes. Also today, NetworkNewsWire released a report on the company detailing today’s announcement of the launch of ISGI’s new $5 million aggregate policy limit for the property and casualty section of its Hospitality Liability coverages offered to InsuraGuest member properties in the hotel and vacation rental sectors. 

InsuraGuest Technologies, Inc. (TSX.V: ISGI) is a leading global SaaS (Software-as-a-Service) company leveraging its proprietary, flagship insurtech (insurance + technology) software, InsuraGuest, which is integrated with the property management systems of hotels and vacation rentals to deliver custom Hospitality Liability coverages.

InsuraGuest’s Hospitality Liability coverages are purchased by hotels and vacation rental properties, which can address claims from guests and their room occupants. The combination of the integrated software and customized insurance provides the property liability coverages the guests benefit from in the event a loss is incurred during their stay.

The Hospitality Liability policy is offered through integration of InsuraGuest’s API with the clients’ property management systems. InsuraGuest’s platform is currently capable of integrating with approximately 71 different hotel and vacation rental property management systems, giving it access to millions of rooms worldwide.

InsuraGuest continues to pursue expansion opportunities in the United States, and has plans to expand to its distribution platform and Hospitality Liability coverages to the United Kingdom and Europe regions by third quarter 2020, as well as expansion into Asia by the end of 2020.

Protection that Enhances the Guest’s Experience

InsuraGuest’s Hospitality Liability coverages add a layer of protection for the property on a primary basis, should a guest experience an accident or theft while staying at an InsuraGuest member hotel or vacation rental property.

Market Opportunity

The U.S. hotel industry generated more than $218 billion in annual revenues in 2018, an increase of $10 billion from the previous year, according to STR’s 2019 HOST Almanac. The European market is more than double the size of the U.S. market. According to Oxford Economics, there were 6.4 billion nights stayed in the world, with 2.6 billion hotel nights stayed in Asia, 2.8 billion nights stayed in Europe, and 1.1 billion stayed nights in the United States. Additionally, $100 billion was spent on vacation rentals in the United States, where there approximately 4.5 million second homes are being managed by a third-party rental company.

With distribution in Europe and the United States, InsuraGuest’s combined demographics will total 3.9 billion nights stayed, and will more than double its vacation rental opportunities.

Within this burgeoning, high-demand industry is risk of liability to guest injury. For example, gym injuries are among the top five most common hotel accidents. Without proper hedges in place, the property may be liable in a personal injury claim or lawsuit that are not the properties fault.

Though the potential for accidents, slip and falls and mishaps can be widespread, it can be covered under the InsuraGuest Hospitality Liability policy to provide guests a worry-free and enjoyable stay that potentially increases loyalty for the property.

Investment Consideration

  • Targeting hotels and vacation rentals, a multi-billion-dollar industry
  • Providing the first line of defense in case of accident, loss or death
  • Expanding distribution reach with footing in European hotel and vacation rental markets
  • Expansion into Asia by 2020

Executive Team

Douglas Anderson, Chairman & Chief Executive Officer
Douglas Anderson has been a businessman in the real estate industry for nearly 30 years. His business expertise includes master planning and development implementation for larger-scale resorts, business parks and commercial developments across the USA and two provinces in Canada. His business endeavors include the founding of the 7th larger private equity fund in America focusing on multifamily and senior care (ROC Fund/Bridge IPG Fund). He serves as chairman/founder of a golf and winter sports ski holding company with operations in four major east coast markets and British Columbia, Canada.

Anderson earned a Bachelor of Science in consumer studies with an emphasis in architecture as an undergraduate at the University of Utah. He subsequently earned his MBA. He also attended a three-year OPM Program a postgraduate business education at Harvard Business School in Boston. Anderson is an avid skier and outdoor enthusiast.

Logan Anderson, CFO & Director
Logan Anderson (bachelor’s degree in communications, accounting and economics) holds the designation of ACA with the Chartered Accountants of Australia and New Zealand. He began his career as an associate chartered accountant in New Zealand and then Canada. This was followed by his position as controller of a management services company which was responsible for the management of numerous private and publicly traded companies. Since 1993, Anderson has served as president of Amteck Financial Corp. (and its predecessors), a private financial consulting services company servicing both private and public companies. He is a former director of 3D Systems, Inc. (NYSE: DDD), and was formerly a founder, officer, and director of Worldbid.com. Anderson has also been involved in raising funds for numerous private and public companies in all stages of their development and has been an officer and director for numerous public and private companies over the past 40 years.

Charles James Cayias, President & Director
Charles James Cayias is also the president and owner of Charles James Cayias Insurance Inc. He is a third-generation insurance professional whose creativity and artistic vision have enabled him to establish a full-service agency combined with the personal service each client deserves. His outstanding people skills, honesty, integrity and fairness are evident by his loyal and growing clientele, the majority of which are referrals who become long-time customers and friends. Cayias began his insurance career in the early 1970s and has been licensed since 1977. He is licensed in all 50 states and specializes in niche programs. He has extensive expertise in all aspects of the insurance industry including commercial insurance, employee benefits, workers’ compensation, professional liability, risk management and bonding.

Tony Sansone, COO & VP of Finance
Tony Sansone has over 30 years of financial, operations and business development experience which includes serving as CFO in the health care, foodservice distribution, manufacturing and technology sectors, including public company experience. He has held senior finance positions in the banking, telecommunications, medical products, and food & drug retailer industries, closing over $430 million of private debt, equity and line of credit financings and over $350 million of a merger, acquisitions, real estate and state incentive transactions, including due diligence, negotiations, closing, and integration. Sansone coordinated and was the executive sponsor for four ERP implementations and multiple other best-in-class software & technology solutions. He received his MBA from the University of Utah and a Bachelor of Science in accounting from Utah State University. Sansone also currently serves as president-elect of the Utah Chapter of Financial Executives International and a past president and current member of the board of trustees for Catholic Community Services of Utah. He is the proud father of three children.

Christopher J. Panos, Vice President & Director
Christopher J. Panos is a highly competitive sales professional with over 15 years of territory manager sales experience and an award-winning record of achievements. He is exceptionally well organized with a proven work history that demonstrates self-discipline, superb communication skills, and the initiative to achieve both personal and corporate goals. Panos is successful in building relationships with a large network of industry professionals in order to grow and maintain new and existing business, exceed new sales objectives and provide in-depth product training to authorized dealers and sales personnel.

Alexander Walker III ESQ, Corporate Counsel & Director
Alexander Walker III ESQ has served as director of the company since September of 2018 and as counsel to the company since July of 2018. Walker is an attorney and has been a member of the Utah Bar Association since 1987 and a member of the Nevada State Bar since 2003. His practice has involved general business litigation, in both federal and state courts, and transactional work, including securities offerings and registration, corporate formation and periodic reporting compliance. Walker has provided legal services to emerging businesses throughout his carrier and at times has served as an officer and board member as well as legal counsel public companies. His duties as legal counsel for a public company engaged in the business of ownership and operation of coal-producing properties in the western United States included oversight of corporate-related legal matters including securities reporting, corporate compliance, federal and state mining regulation, and employment law oversight. He also has served as the chair of the Mining Committee of the Energy, Natural Resources and Environmental Law Section of the Utah State Bar, a member of the board of directors of the South East Utah Energy Producers Association, the co-chair of the board of the Western Energy Training Center, a board member of the Utah Supreme Court Committee to Review the ABA Recommendations Regarding the Office of Professional Conduct, and a board member of the University of Utah Crimson Club.

Jennifer Epperson, Vice President of Sales
Jennifer Epperson has over 20 years of B2B sales experience with exceptional success history. She has grown and developed sales territories across multiple industries. Her ability to find and develop strategic relationships has given her top-level performance throughout her career. Epperson’s passion and knowledge provide an inherent ability to connect and retain relationships for the growth of the company. Throughout her professional career, she has achieved peak performance sales results and awards year after year. She captures the vision of the company and drives it forward with enthusiasm and expertise. Her commitment to providing an exceptional customer experience has been the key to her success.

Richard Matthews, Interim Financial Controller
Richard Matthews joined the InsuraGuest team in March 2019 as the interim financial controller. Leading the Finance and Audit team, Matthews is responsible for the delivery of financial services such as accounting, treasury, reporting, budgeting and insurance management, in accordance with legislative requirements and organizational policies and strategies. He has over 30 years of experience in providing professional services across a broad range of finance areas including compliance, business process, audit, and financial reporting. He holds a degree in accounting from the University of Utah and is a licensed CPA in the state of Utah.

Roger Bloss, Corporate Consultant & Board Advisor
Roger Bloss joined InsuraGuest in August of 2019 to advise the company and its board on hotel transactions, contributing his knowledge from more than 40 years in the hospitality industry. Bloss previously served in executive positions with several major hotel franchise companies and in 1996 founded Vantage Hospitality Group hotel brands. Under his leadership, Vantage became a Top 10 global hotel company and made the Inc. 500/5000 list of Americas’ fastest-growing private companies for eight straight years. Bloss was named Lodging Magazine’s “Innovator of the Year” in 2006 and 2010, and in 2009 earned a spot on HSMAI’s “Top 25 Extraordinary Minds in Sales and Marketing.” Bloss joined Red Lion Hotels Corporation (RLHC) in September 2016 in conjunction with the acquisition of Vantage.

Jim Kilduff, Board Advisor
James “Jim” C. Kilduff has nearly 40 years of experience in the insurance and risk management sectors. He is a dynamic and energetic team leader and builder with extensive experience in the changes affecting the insurance business through Gas, alternative distribution, insurtechs and program business. His skillset includes experience as chief insurance officer with Outdoorsy Insurance Group, CEO with Harbor Hill Solutions Inc., and senior vice president and chief marketing officer with State National Insurance Companies. His career has spanned MGA creation and management, insurance company management, business development and underwriting, primary insurance and reinsurance.

Don Archibald, Board Advisor
Don Archibald brings to InsuraGuest’s advisory board 54 years of experience as an insurance agent. Archibald is the founder and former owner of Archibald Clarke and Defieux (ACD Insurance), as well as the co-founder and former equity partner of Sussex Insurance, and an agent with Sussex since 2014.

InsuraGuest Technologies, Inc. (TSX.V: ISGI), closed Monday's trading session at $0.135, off by 15.62%, on 10,500 volume with 6 trades. The average volume for the last 3 months is 24,500 and the stock's 52-week low/high is $0.045/$0.34.

Recent News

chart

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) today announced that it will release its first quarter 2020 results after the close of markets on Thursday, May 14, 2020. In addition, VIVO Cannabis’ senior management will host a conference call at 10 a.m. ET on Friday, May 15, 2020, to discuss the results. Interested parties may join the call by dialing 647-427-7450 or 1-888-231-8191 and entering conference ID: 8835659. The live webcast may be accessed by visiting http://cnw.fm/x2Jhw and will be archived for 90 days. To view the full press release, visit http://cnw.fm/5sMsF

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed Monday's trading session at $0.1989, up 16.1121%, on 178,216 volume with 52 trades. The average volume for the last 3 months is 159,875 and the stock's 52-week low/high is $0.279000014/$4.03999996.

Recent News

chart

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT)

The QualityStocks Daily Newsletter would like to spotlight Blue Hat Interactive Entertainment Technology (BHAT).

Blue Hat Interactive Entertainment Technology ("Blue Hat" or the "Company") (NASDAQ: BHAT), a producer, developer and operator of augmented reality ("AR") interactive entertainment games, toys and educational materials in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2019 with the U.S. Securities and Exchange Commission (the "SEC") on May 11, 2020. The annual report on Form 20-F, which contains the Company's audited consolidated financial statements, can be accessed through the SEC's website at http://www.sec.gov or the Company's investor relations website at http://ir.bluehatgroup.com.

Blue Hat Interactive Entertainment Technology (BHAT) is a cutting-edge creator, developer and operator of popular augmented reality (“AR”) interactive smart toys and educational games in China. Blue Hat’s mobile-connected entertainment platform connects physical items to mobile devices through wireless technologies, creating a unique interactive user experience in various mobile games, interactive educational materials and toys with mobile game features.

Blue Hat designs original toys and games that utilize augmented reality technology, motion capture technology, image recognition technology, voice control, light sense technology, infrared, levitation induction, and other trending scientific technologies to transverse the virtual with reality. Blue Hat creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. This combination provides users with a more natural form of human computer interaction, enhances a user’s perception of reality, and delivers a more immersive entertainment experience.

Proprietary Technology

Founded in 2010, Blue Hat’s proprietary technology, product research and development, marketing channels and brand operation are the cornerstones of the business. Blue Hat focuses on the combination of “online” and “offline” activity and the interaction between “entertainment” and “product” to create a high-tech entertainment platform combining mobile games and AR. With the help of computer graphics, motion capture technology, image recognition technology and visualization technologies, Blue Hat accurately “places” virtual objects into the physical world, creating a new and stimulating visual environment for users.

Blue Hat recently displayed a variety of its sci-tech products at the Guangzhou International Toy Exhibition in China including AR Racer, Elastic Bubbles, AR Space Track, AR Alloy Toy Car, AR Need a Spanking, 5D Animated Magic Aquarium, Bug Travelers, AR Picture Book and other interactive games and smart toys.

The company has multiple products in development including new generations of four primary product lines and two new product lines.

Patents and Copyrights

Blue Hat’s advanced AR technology in interactive entertainment is protected by 178 authorized patents with 44 patents in various stages of the application process.

Another 14 applications for Patent Cooperation Treaty, or PCT, have been filed for international patents. As of March 31, 2019, the company owns 645 copyrights for artwork, 71 registered trademarks and 27 software copyrights.

Sales and Marketing

There has been rapid growth in the toys and games industry in China over the last several years. Total retail sales of toys and games in China soared from RMB 111.8 billion in 2012 to RMB 276.5 billion in 2017 with an average annual growth rate of 19.9% in 2017. Blue Hat believes the company is well positioned with little competition as the toy industry rapidly shifts toward intelligent and interactive toys and games. Retail sales of electronic toys grew at 24% annually in 2017 while that of traditional toys grew at 7%.

In addition to a powerful ecommerce presence, Blue Hat has long-term relationships with partnered distributors that place the company’s AR interactive entertainment products into well-known international retail chains and retail outlets. Blue Hat’s integrated online and offline sales channels include e-commerce giants such as Amazon and Alibaba, retail chain stores and the company’s physical experience store located in Xiamen, China. Blue Hat plans to open or franchise approximately 100 additional stores in China by 2021.

Blue Hat’s community-based platform offers users a highly engaged and interactive community with online communication forums and offline social activities. The company advocates a new model of “teaching through lively activities” and combines AR technology with education, integrating its products into situational teaching, roleplaying and man-machine interaction. This novel educational experience helps realize optimal transformation of information, creating a knowledge and enhancing cognition.

Management

Director and CEO Xiaodong (Sean) Chen has over 20 years of experience creating, developing and producing toys and games related products. Chen earned his EMBA from Renmin University of China and has been chairman of the board of directors and general manager of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.

CFO and Director Caifan, who has over 20 years of financial accounting and taxation experience, earned a degree in finance from Hunan University of Finance and Economics. He has served as director, deputy general manager and financial controller of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.

Jianyong Cai, chief technology officer and director, has over 35 years of experience in data communication principles, communication network foundation, software engineering, communication network theory and technology and computer network architecture. He holds degrees in data communication principles, communication network foundation and software engineering from University of Science and Technology of China. He has been director, deputy general manager and chief engineer of Fujian Blue Hat Interactive Entertainment Technology Ltd. since January 2010.

Blue Hat Interactive Entertainment Technology (BHAT), closed Monday's trading session at $1.18, up 0.85%, on 76,371 volume with 349 trades. The average volume for the last 3 months is 168,656 and the stock's 52-week low/high is $0.038600001/$0.230000004.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) was featured in a recent article that described the launch, through its 7ACRES division, of meetyourtastebuds.com, an interactive website designed to help consumers across the country find the perfect strain. "We are very excited to launch this interactive tool and help consumers distinguish their cannabis taste preferences,” Supreme Cannabis VP, Marketing & Communications, Nicole Sale, stated in the article. To view the article, visit http://cnw.fm/dB9e2. Also today, the company was highlighted in a publication from Financialnewsmedia.com, examining how the CBD market surge in the last few years has been well documented and all reports seem to project continued growth of revenues over the coming years. CNN said, "These hemp farmers are getting rich with CBD." For farmers, growing hemp is a booming business. And it's much more profitable than growing corn or soybeans. In the U.S., sales could surge… from $591 million last year . . . to $22 billion within just three years." Additionally, SPRWF was featured in today's edition of the Investorideas.com potcastsCM. Listen to the podcast: http://ibn.fm/eCkEw

Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF) is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees and culture of innovation. The company aims to grow the world’s best legal cannabis and become a leader in the global industry. Supreme Cannabis calls its Toronto Venture Exchange stock symbol, “FIRE,” a testament to the company’s passion for cannabis and obsession with quality.

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as one of Canada’s most premium cannabis producers, the company sees itself at the center of this global shift.

A key piece of Supreme Cannabis’ ability to fulfill its mission is its flagship brand, 7ACRES, a wholly owned subsidiary that operates a 440,000-square-foot hybrid cultivation facility in Kincardine, Ontario. 7ACRES is focused on building a core competency in scaled high-quality cannabis production. With a best-in-class cultivation facility producing a competitive product that fuels a leading premium brand, Supreme Cannabis has achieved a differentiated advantage in cultivation IP, products and branding. The company’s foundational investment in premium cultivation has secured it a leadership position in the industry as the Canadian market becomes more competitive and matures.

Since legalization, 7ACRES has brought five premium flower strains to market in Canada. The demand for 7ACRES product continues with the company’s most recent launch of Jack Haze, a new proprietary premium cultivar. The company’s first sativa-dominant strain, Jack Haze offers rare sensory characteristics, delivering high THC content with a terpinolene forward profile, including a complex aroma with notes of citrus, pine and warm spice. As it develops its next winning strain, 7ACRES continues to prioritize subjective quality. In the Canadian cannabis market, this approach has established 7ACRES as a well-known premium brand that commands premium pricing coast-to-coast.

In addition to 7ACRES, Supreme Cannabis has built a diversified portfolio of focused consumer-driven brands:

  • Sugarleaf by 7AC – this new brand widens Supreme Cannabis’ product offerings and targets consumers who are looking for more refined, milder consumption experience as they discover their own cannabis taste preferences and desires. Product formats under this brand are focused on offering consumers elegant and convenient cannabis experiences.
  • Blissco — dedicated to providing wellness focused consumers with premium cannabis products, education, and outstanding customer care. Blissco is focused on bringing its collection of premium whole-flower CBD oils to market.
  • Truverra — focused on being a global leader in the development, production and marketing of hemp and cannabis-derived medicinal products with clinically proven efficacy. With over 25 SKUs sold online in the UK and Europe, Truverra is ideally positioned to address emerging international cannabis opportunities.
  • Khalifa Kush Enterprises — formed through a prestigious international partnership with Khalifa Kush Enterprises (KKE) Canada, the Canadian counterpart to the popular U.S. cannabis brand KKE formed by Wiz Khalifa. Together, Supreme Cannabis and KKE Canada are developing and launching a lineup of premium cannabis products, including a future line based on the well-known Khalifa Kush strain.

Each of Supreme Cannabs’ brands and partnerships have been strategically identified and designed to support the company’s mission to enhance the lives of consumers through positive cannabis experiences. Equally important to delivering desirable consumer experiences is the infrastructure supporting the company’s brands and products. From seed to sale, supreme cannabis continues to build an impressive group of operating assets that serve key functions throughout the value chain:

  • Cultivation – for starters, there is Supreme Cannabis’ foundational flagship asset, its 440,000-square-foot cultivation facility in Kincardine, Ontario. With over 600 employees, 24 grow rooms, and best-in-class processing equipment and procedures, this facility is expected to reach an annual production capacity of 50,000 kilograms in the near-term. In this purpose-built facility, the company grows small-batch high-quality cannabis from 10,000-square-foot grow rooms and completes a proprietary hang-dry for up to two weeks.
  • Extraction – with the acquisition of Blissco in fiscal 2019, in addition to the Blissco wellness brand, Supreme Cannabis gained a 12,000-square-foot dedicated extraction facility in Langley, BC. This facility conducts both C02 and ethanol extraction and with the recent receipt of its oil sales license from Health Canada, it now produces Blissco branded CBD oils and expects to fill vaporizer pods for a partnership between the company’s 7ACRES brand and Pax Labs.
  • Manufacturing – most recently, the company announced its 107,000-square-foot processing, packaging and manufacturing facility in Kitchener, naming the facility Supreme Cannabis Kitchener. In Q4 FY2020, the company expects to begin whole flower packaging and pre-roll manufacturing for Supreme Cannabis brands at the Kitchener Facility. In the long-term, in additional to processing its own inputs, Supreme Cannabis intends generate incremental revenue by packaging, distributing and branding third-party cannabis inputs from quality-focused cultivators.
  • R&D and Product Testing – In Q1 FY2020, Supreme Cannabis closed the acquisition of Truverra and acquired a 5,000-square-foot facility licensed under Canadian Clinical Cannabinoids Inc. in Scarborough, Ontario (“Supreme Cannabis Scarborough”). Supreme Cannabis Scarborough provides R&D space for the company to test new products and develop medicinal science intellectual property. In the near-term, with the legalization of 2.0 cannabis products, this centre for innovation will be testing and bringing concentrate products to market under the 7ACRES brand.

Supreme is committed to continue to identify new opportunities to grow and strengthen its impressive portfolio of operating assets and brands and scale its strong Canadian business globally.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Monday's trading session at $0.19, even for the day, on 313,268 volume with 173 trades. The average volume for the last 3 months is 556,032 and the stock's 52-week low/high is $0.004/$0.021999999.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that it will report its financial results for the fourth quarter and fiscal year ended March 31, 2020 before markets open on Friday, May 29, 2020. According to the update, the Company will also host a conference call and audio webcast, led by its President and CEO Narbé Alexandrian and CFO Eddie Lucarelli, following release of its results. To register and log into the live audio webcast, visit http://cnw.fm/nnt0P. To view the full press release, visit http://cnw.fm/UOvk0.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (CNPOF), closed Monday's trading session at $0.61, off by 5.5668%, on 55,539 volume with 96 trades. The average volume for the last 3 months is 98,666 and the stock's 52-week low/high is $2.73000001/$5.48999977.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today confirms that its private placement financing as previously announced on May 4, 2020 (the "Offering") closed pursuant to two tranches. The Company confirms that it has issued an aggregate 8,028,254 shares ("Shares") of its common stock along with common stock purchase warrants ("Warrants") to purchase up to 8,028,254 shares of its common stock pursuant to the Offering for gross proceeds of US$1,846,498 million in its first tranche closing which occurred on May 6, 2020. The Company closed the second tranche of its private placement on May 11, 2020 for the further issuance of 837,957 Shares along with 837,957 Warrants for gross proceeds of US$192,730. 

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hemp-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Monday's trading session at $0.2632, off by 7.972%, on 101,207 volume with 49 trades. The average volume for the last 3 months is 107,217 and the stock's 52-week low/high is $0.05/$3.00.

Recent News

chart

Xalles Holdings Inc. (OTC: XALL)

The QualityStocks Daily Newsletter would like to spotlight Xalles Holdings Inc. (OTC: XALL).

Xalles Holdings (OTC: XALL), a holding company that focuses on acquisition and support of disruptive fintech companies, today announced that its CEO Thomas Nash was featured in The Stock Day Podcast hosted by Everett Jolly. In the interview, Nash described the company’s recent acquisitions, as well as its developments with blockchain and tokenization. To view the full press release, visit http://ccw.fm/gJp1S.

Xalles Holdings Inc. (OTC: XALL) is a fintech holding company leveraging blockchain and other technologies for e-commerce, payments, financial reconciliation, and payment auditing solutions. The company actively seeks acquisition targets with strong management teams and business models, large total attainable markets, and lucrative exit opportunities in which to invest and accelerate growth.

Operations

The common element to all acquired entities and projects is a business model that involves setting up a payment or financial transaction “toll gate,” thereby creating a recurring revenue stream.

Xalles’ business plan focuses on consumer, business and government-oriented payment and financial reconciliation transactions. Combining the blockchain decentralized financial ledger platform with the company’s existing X2X transaction reconciliation system design, Xalles is building technology that supports payment audits, exchanges, and new business models and opportunities worldwide. Xalles will launch new services card and mobile payment and rewards systems, and will expand the technology offerings for referral marketing and e-commerce engines.

Subsidiaries
(all current subsidiaries are wholly owned)

  • Xalles Holdings
    Raise capital for fintech accelerator program acquisitions, provide management, administrative, finance and marketing support to all subsidiary companies
  • Xalles Capital
    Management support of investment consortiums, direct investment into funds or projects, and management of investments
  • Xalles Limited
    Design and market new X2X solutions; acquire U.S Government transportation post-payment audit business through GSA schedule and expand to non-transportation payment auditing
  • Xalles Technology
    Technical development of the X2X blockchain systems
  • Xalles Financial Services
    Consumer and small business financial service offerings
  • Co-Owners Rewards
    Stock-based rewards system for payments cards and financial services
  • Amazing Living Enterprises
    Affiliate program and e-commerce platform for enhancing financial lives
  • Global Savings Network
    Not-for-profit fundraising system with consumer discounts at local merchants

X2X Solutions

Xalles provides payment and financial transaction management solutions through the company’s proprietary blockchain-based X2X technology. The X2X solution includes the Investment and Financing System (IFS), which supports complex investment structures, assists international investment consortia, and provides links to Xalles’ Financial Transaction Reconciliation (FTR) solution. FTR supports complex financial ecosystems, making it easier for parties to exchange products, services, grants and government incentives, and assists “Exchange Managers” with liquidity and auditability. X2X also supports the Xalles pre- and post-payment auditing services.

Plans for 2020

  • Xalles expects to announce new acquisitions of fintech growth firms.
  • The company’s strategy for 2020 includes revamping its consumer Commerce platform, to bring in the best elements of local and online shopping with payment tools and a unique rewards program.
  • Xalles Financial Services expects to expand its cryptocurrency related service offerings through partnerships, acquisitions and organic growth
  • The Blockchain based X2X system will continue to be enhanced to deliver new financial reconciliation services to large enterprises and governments.

Xalles Holdings Inc. (OTC: XALL), closed Monday's trading session at $0.00524, off by 14.0984%, on 6,045,266 volume with 111 trades. The average volume for the last 3 months is 6,152,321 and the stock's 52-week low/high is $0.150000005/$3.23000001.

Recent News

chart

National Storm Recovery Inc. (OTC: NSRI)

The QualityStocks Daily Newsletter would like to spotlight National Storm Recovery Inc. (NSRI).

National Storm Recovery Inc. (OTC: NSRI), through its subsidiaries, including National Storm Recovery, LLC (DBA Central Florida Arbor Care and Mulch Manufacturing, Inc.), provides tree services, debris hauling, removal and bio-mass recycling, manufacturing, packaging and sales of next-generation mulch products. The company’s primary corporate objective is to provide a solution for the treatment and handling of tree debris that is historically sent to local landfills and disposal sites, creating an environmental burden and pressure on disposal sites around the nation.

Environmentally Friendly

National Storm and the solutions provided by its Sustainable Green Team are founded in sustainability. The company’s vertically integrated operations begin with the collection of tree debris through its tree services division and collection sites. Tree bio-mass is then moved through the processing division for recycling and manufacturing into a variety of organic, attractive, next-generation mulch products to be packaged and sold to retailers, landscapers, installers and garden centers.

The company’s solutions create a synergistic and environmentally beneficial solution to tree and storm waste disposal that historically has created an environmental burden on landfills and disposal sites around the nation.

National Storm’s customers include governmental, residential and commercial customers and now big box retailers. The company is headquartered in Florida.

Strategic Acquisition

National Storm in February 2020 acquired 35-year-old industry leader and innovator Mulch Manufacturing, Inc., an Ohio corporation. Structured as a share exchange, this strategic partnership provides National Storm with a significantly larger footprint in the mulch industry.

The acquisition includes Mulch Manufacturing’s national and international distribution agreements, an increase in production and packaging capacity, and its sales contracts with numerous big box retailers. Mulch Manufacturing includes mulch production, sawmill operation, Natures Reflections colorant manufacturing and equipment manufacturing.

Next-Gen Products

National Storm’s vision and commitment to the environment is paired with Mulch Manufacturing’s revolutionary “next-generation” mulch product, Nature’s Reflection’s Softscape®.

Softscape mulch products, created from natural forest products, are color-enhanced with environmentally safe colorants to provide four-year color retention and are free from contaminants. Safe for people and pets, Softscape allows water and air to penetrate soil and roots, which is vital to plant health and growth.

Expansion Plans

National Storm plans to expand its operations through a combination of organic growth, through its partnership with a nationally recognized waste disposal company, and through strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified.

The company has received final zoning approval for its 100-acre site, located in Lake County, Astatula, Florida, which will serve as the company’s flagship tree debris collection site. The facility will also house the company’s mulch manufacturing, soil composting and production bagging. This prime location includes a 5,000-square-foot building that contains warehouse and office space. The 100-acre property can accommodate millions of cubic yards of organic debris and will allow National Storm’s debris hauling division to realize significant savings on its transportation costs.

National Storm has chosen as its new headquarters the Mulch Manufacturing 100,000-square-foot building in Jacksonville, Florida. The facility comprises centralized operations of Mulch Manufacturing, Inc. and National Storm Recovery, LLC, and has ample room to expand as the needed.

Leadership

National Storm’s Sustainable Green Team boasts more than 40 years of next-level experience with mulch manufacturing, treating and caring for trees. This team is guided by a roster of highly qualified professionals:

  • Tony Raynor, Chief Executive Officer
  • Edward Lee, Chief Operating Officer
  • Ralph Spencer, Director of Business Development, Strategic Acquisitions
  • Steve Ogden, ISA-Certified Arborist
  • Rick Starcher, Master Chemist
  • Peder K. Davisson, Esq., Corporate/Securities Counsel

National Storm Recovery Inc. (OTC: NSRI), closed Monday's trading session at $0.79, up 690.00%, on 1,611 volume with 9 trades. The average volume for the last 3 months is 853 and the stock's 52-week low/high is $0.239999994/$1.50.

Recent News

chart

Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Bolt Metals Corp. (OTCQB: PCRCF).

Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade battery metals deposits within the Asia-Pacific region, employing a vertically integrated “minerals-to-market” strategy to leverage these assets to their fullest.

Bolt Metals Corp. is advancing its flagship, 100% controlled Cyclops Nickel-Cobalt located in Papua Province, Indonesia with a mandate to become a key contributor to Asia-Pacific’s rapidly expanding electric vehicle and battery supply chain.

The Cyclops project, uniquely positioned within the world’s largest producer of nickel and in proximity to China, the world’s largest “Gigafactory”, features near surface, strong nickel-cobalt mineralization. The property is situated in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Bolt Metals well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to nickel-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Indonesia has recently approved environmental impact studies for factories to produce battery-grade nickel chemicals in Morowali. The approval will allow investors, such as China’s stainless steel giant Tsingshan Group, to continue the construction of their high-pressure acid leaching plants in Morowali, Central Sulawesi.

Ranjeet Sundher, chief executive officer of Bolt Metals, said: “Indonesia continues to make significant strategic decisions, and this latest announcement represents an important step in Bolt Metals’s efforts to benefit from Indonesia’s rapid development as a leading market for all stages of the EV supply chain. With offices in Vancouver, Shanghai and Jakarta, Bolt Metals is well positioned to leverage Asia’s global dominance in the battery manufacturing sector.”

Indonesia’s commitment extends to the very top of government, with Joko Widodo – Indonesia’s President – stating in September 2019 that “for nickel, we want raw materials to be processed in Indonesia. We want added values”. This supports previous pronouncements from key officials, including Indonesian Maritime Minister, Luhut Pandjaitan who remarked that Indonesia will “become the main player in lithium batteries” and that it will “control the world market”.

The country, which is the world’s top nickel ore exporter, has stopped export of unprocessed nickel ore to support this plan.

During 2019 the Company carried out an extensive exploration and development program on Cyclops and achieved successful nickel results with its drilling and bench-scale scoping tests for processing of materials.

Drilling identified significant horizons of nickel mineralization and bench-scale scoping tests returned positive results for processing of this nickel rich material.

The recovery percentages form the bench-scale test program are set out below (for further information, please refer to the Company’s press release of October 28, 2019):

Sample Nickel (%) Cobalt (%) Iron (%)
Limonite 99.26 98.82 97.77
Low Iron Transition 99.75 97.03 99.22
Saprolite 99.77 >99.9 99.74

 

Selected elevated nickel drill results are provided below from the Company’s shallow drilling program (for further information, please refer to the Company’s press releases of March 5, April 1, April 23, June 13, June 20 and September 10, 2019):

Intersection length (metres from surface) Nickel (%) Cobalt (%)
7.0 2.15% 0.03%
4.0 1.96% 0.04%
2.0 2.00% 0.01%
2.0 1.91% 0.05%

 

2020 will see continued and consistent development in Pacific Rim Cobalt’s strategy as the company continues to set ambitious milestones with the goal of becoming a leading international player in the EV battery metal sector and creating significant long-term shareholder value.

This includes preparations to commission and operate the company’s pilot plant in Canada, which will contain an integrated circuit to produce high-purity nickel and cobalt strip solutions to develop battery-grade nickel and cobalt.

The results of the pilot plant will then be used to establish the design criteria for the subsequent demonstration plant in Indonesia, which will produce nickel and cobalt products suitable to meet market specifications. As well as demonstrating Pacific Rim Cobalt’s ability to produce a product within market specifications, this will also be used to establish the design criteria for the company’s commercial-scale plant.

Pacific Rim Cobalt’s world-class management team includes Ranjeet Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Bolt Metals Corp. (OTCQB: PCRCF), closed Monday's trading session at $0.112, up 6.5652%, on 14,157 volume with 12 trades. The average volume for the last 3 months is 54,868 and the stock's 52-week low/high is $0.460999995/$2.94000005.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Monday's trading session at $3.84, up 4.065%, on 17,498 volume with 37 trades. The average volume for the last 3 months is 11,611 and the stock's 52-week low/high is $0.101000003/$1.54999995.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.